scholarly journals A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report

2011 ◽  
Vol 4 (1) ◽  
pp. 8 ◽  
Author(s):  
Cristiano Rocha ◽  
Inka Praulich ◽  
Iris Gehrke ◽  
Michael Hallek ◽  
Karl-Anton Kreuzer
2020 ◽  
Vol 4 (1) ◽  
pp. 61
Author(s):  
Salwa Bano ◽  
Veena Ramaswamy ◽  
BN Tejaswini ◽  
Chaitra Chandrashekar

Cureus ◽  
2017 ◽  
Author(s):  
Farhan Mohammad ◽  
Gwenalyn Garcia ◽  
Shiksha Kedia ◽  
Juan Ding ◽  
Matthew Hurford ◽  
...  

2013 ◽  
Vol 2 (1) ◽  
Author(s):  
Long Yang ◽  
Beth Harrison ◽  
Mary Ann Perle ◽  
Mandeep Singh ◽  
Zhiheng Pei ◽  
...  

2020 ◽  
Author(s):  
Yanfeng Jiang ◽  
Zhiming Zeng ◽  
Lihua Yang ◽  
Jie Zeng ◽  
Fengyan Qin ◽  
...  

Abstract Background Composite lymphomas (CLs) are a kind of rare disease that two distinct categories of lymphomas occur in the same patient. Histologically, composite lymphomas can be composed of a Hodgkin’s lymphoma and a non-Hodgkin lymphoma or two distinct non-Hodgkin lymphomas. So far, most of the cases have been reported to occur in a single anatomical site or mass. Case presentation: A 61-year-old man without any B-type symptoms complained of an enlarging mass in the abdomen for one month. A 10 × 10 cm abdominal mass could be touched in the hypogastric region. Through pathological biopsy, mantle cell lymphoma can be diagnosed. After one cycle chemotherapy regimen of FCD, red rashes and blisters came out on the patient's right lower extremity. Cutaneous diffuse large B-cell lymphoma (DLBCL) was diagnosed by skin biopsy. In this report, we describe a case of composite lymphoma occurring in different organs, which consisted of primary mantle cell lymphoma (MCL) and cutaneous DLBCL, leg type. The patient then received a series of chemotherapy regimens without rituximab then achieved partial response (PR). Conclusions To our knowledge, this is a rare case of CLs occurring in different anatomic sites that were treated by chemotherapy and achieved PR. As we learn more about the mechanisms and treatment of CLs, we look forward to more treatment options in the future for patients to give them a better prognosis.


2012 ◽  
Vol 138 (suppl 2) ◽  
pp. A225-A225
Author(s):  
Long Yang ◽  
Beth Harrison ◽  
Mary Ann Perle ◽  
Mandeep Singh ◽  
Zhiheng Pei ◽  
...  

2006 ◽  
Vol preprint (2007) ◽  
pp. 1
Author(s):  
Kristi Smock ◽  
Hassan Yaish ◽  
Mitchell Cairo ◽  
Mark Lones ◽  
Carlynn Willmore-Payne ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document